Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
36.32
+0.30 (0.83%)
Aug 15, 2025, 4:00 PM - Market closed

Revolution Medicines Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Cash & Equivalents
402.44543.06696.15161.41108.5104.27
Upgrade
Short-Term Investments
1,7351,7461,157483.53468.56336.47
Upgrade
Cash & Short-Term Investments
2,1372,2891,853644.94577.05440.74
Upgrade
Cash Growth
34.35%23.55%187.31%11.77%30.93%259.03%
Upgrade
Receivables
--1.254.675.936.39
Upgrade
Prepaid Expenses
39.2738.3325.0710.576.796.99
Upgrade
Total Current Assets
2,1762,3281,879660.19589.77454.12
Upgrade
Property, Plant & Equipment
147.05141.82100.0173.7471.2436.34
Upgrade
Goodwill
14.6114.6114.6114.6114.6114.61
Upgrade
Other Intangible Assets
56.1456.6757.7458.8159.8860.95
Upgrade
Long-Term Deferred Charges
----0.5-
Upgrade
Other Long-Term Assets
35.3417.5710.064.5921.39
Upgrade
Total Assets
2,4302,5582,062811.93737.99567.4
Upgrade
Accounts Payable
56.7654.4361.7921.3114.0612.61
Upgrade
Accrued Expenses
114.2296.0370.828.9427.4118.69
Upgrade
Current Portion of Leases
13.0912.877.376.776.213.67
Upgrade
Current Unearned Revenue
---4.4612.3612.11
Upgrade
Other Current Liabilities
0.460.583.90.510.310.1
Upgrade
Total Current Liabilities
184.53163.91143.8561.9860.3547.18
Upgrade
Long-Term Leases
119.7122.9780.5857.4360.4228.99
Upgrade
Long-Term Unearned Revenue
----6.578.48
Upgrade
Long-Term Deferred Tax Liabilities
2.352.353.127.037.447.44
Upgrade
Other Long-Term Liabilities
257.613.867.970.30.630.63
Upgrade
Total Liabilities
564.2293.1235.51126.74135.4292.73
Upgrade
Common Stock
0.020.020.020.010.010.01
Upgrade
Additional Paid-In Capital
4,0634,0022,9631,3881,056740.1
Upgrade
Retained Earnings
-2,199-1,738-1,138-701.34-452.64-265.55
Upgrade
Comprehensive Income & Other
1.31.320.54-1.78-0.380.12
Upgrade
Total Common Equity
1,8652,2651,826685.19602.57474.68
Upgrade
Shareholders' Equity
1,8652,2651,826685.19602.57474.68
Upgrade
Total Liabilities & Equity
2,4302,5582,062811.93737.99567.4
Upgrade
Total Debt
132.79135.8487.9464.2166.6332.66
Upgrade
Net Cash (Debt)
2,0042,1531,765580.74510.42408.08
Upgrade
Net Cash Growth
33.33%22.01%203.93%13.78%25.08%232.97%
Upgrade
Net Cash Per Share
11.1712.8415.607.207.017.44
Upgrade
Filing Date Shares Outstanding
186.93185.91164.6990.4974.1973.38
Upgrade
Total Common Shares Outstanding
186.9185.9164.6790.4174.1466.6
Upgrade
Working Capital
1,9922,1641,735598.2529.42406.95
Upgrade
Book Value Per Share
9.9812.1911.097.588.137.13
Upgrade
Tangible Book Value
1,7952,1941,754611.77528.08399.12
Upgrade
Tangible Book Value Per Share
9.6011.8010.656.777.125.99
Upgrade
Machinery
36.2431.4428.0921.7414.9811.6
Upgrade
Construction In Progress
0.50.390.51-0.131.98
Upgrade
Leasehold Improvements
21.3414.2811.9511.47.253.39
Upgrade
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q